Cargando...
Chemotherapeutics in the treatment of multiple sclerosis
The likely pathogenic mechanisms of multiple sclerosis (MS) provide a sound rationale for investigating the efficacy of drugs possessing immunosuppressive or immunomodulatory properties. With proven efficacy, safety and tolerability, interferon beta formulations and glatiramer acetate have become th...
Guardado en:
Autores principales: | , |
---|---|
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
SAGE Publishing
2010-09-01
|
Colección: | Therapeutic Advances in Neurological Disorders |
Acceso en línea: | https://doi.org/10.1177/1756285610379885 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|